Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,814 | Dovepress* | 6,309+ | 1,330 | 7,639 | |
PubMed Central* | 505 | 185 | 690 | ||
Totals | 6,814 | 1,515 | 8,329 | ||
*Since 25 July 2016 |
View citations on PubMed Central and Google Scholar